Top Markets
Coin of the day
Ortin Laboratories Limited Ortin Laboratories Limited

Ortin Laboratories Limited

ORTINLAB
Pozycja w akcjach #37115
Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad,... Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad, India, in 1986, is engaged in the manufacturing and commercialization of a diverse range of medicines, drugs, and chemical intermediates. The company provides a wide array of pharmaceutical formulations, presented as tablets, capsules, syrups, and dry powders. These products target various therapeutic domains such as metabolic diseases (e.g., anti-diabetics), allergic reactions, infections (including broad-spectrum antibiotics and antifungals like quinolones, penicillins, cephalosporins, macrolides, and antifungals), pain management and fever reduction (analgesics and antipyretics), cardiovascular ailments (anti-anginal and cardiovascular products), digestive system disorders (antacids and anti-ulcerants), neurological and psychiatric conditions (sedatives, tranquilizers, psychiatry products), and nutritional supplementation (like vitamins, calcium, iron, and protein supplements). Specialized offerings also include anti-retroviral, anti-arthritic, anti-helminthic, anti-spasmodic, gynaec, appetite stimulators, and chemotherapeutic preparations. In addition to finished pharmaceuticals, Ortin produces active pharmaceutical ingredient (API) intermediates for applications such as anti-retrovirals, anti-diabetics, pain and fever medications, antibiotics, antifungals, antacids, anti-malarials, and anti-ulcerants. Its manufacturing capabilities also extend to fine chemicals and Grignard/alkali metal compounds. The company offers specialized services covering process development and characterization, analytical research, assay development, and product characterization. It also contributes to diagnostics through the development of rapid flow kits, assays, and reagents. Ortin Laboratories undertakes long-term contracts for the production of intermediates and the creation of novel APIs. Moreover, it actively functions as a merchant exporter of its finished pharmaceutical products.
Cena akcji
$0.2488447
Ostatnia synchronizacja: 2024-10-01
Kapitalizacja rynkowa
$2.01M
Zmiana (1 dzień)
-1.88%
Zmiana (1 rok)
0.00%
Kraj
IN
Handel Ortin Laboratories Limited (ORTINLAB)

Kategoria

Cena ORTINLAB z kapitalizacją rynkową B
Ortin Laboratories Limited Ortin Laboratories Limited
ORTINLAB
$0.2488447
Kapitalizacja rynkowa Ortin Laboratories Limited(ORTINLAB)
Kapitalizacja rynkowa: $2.01M
Na dzień August 2026 spółka Ortin Laboratories Limited ma kapitalizację rynkową wynoszącą $2.01M. Według naszych danych, czyni to Ortin Laboratories Limited 37115th najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej Ortin Laboratories Limited od 2015 do 2026
ORTINLAB w porównaniu do 5 najpopularniejszych stocks
Cena za ORTINLAB Aktywa B Kapitalizacja rynkowa B Wyniki
Ortin Laboratories Limited Ortin Laboratories Limited
$674,711 $2.01M
$5.452T +271,137,165.72%
Ortin Laboratories Limited Ortin Laboratories Limited
$555,675 $2.01M
$4.490T +223,301,684.13%
Ortin Laboratories Limited Ortin Laboratories Limited
$515,130 $2.01M
$4.162T +207,008,527.69%
Ortin Laboratories Limited Ortin Laboratories Limited
$454,976 $2.01M
$3.676T +182,835,120.07%
Ortin Laboratories Limited Ortin Laboratories Limited
$350,611 $2.01M
$2.833T +140,895,363.49%